Sugi Predict

Sugi Predict / Compounds / SCHEMBL10128484

SCHEMBL10128484

SCHEMBL10128484

CCCc1ccc2c(c1)c1ccccc1c1nnc(-c3ccc(Br)cc3)n21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.42
▸ MAPT P10636 2/20 0.38
▸ RORA P35398 2/20 0.38
▸ RORC P51449 2/20 0.38
▸ RORB Q92753 2/20 0.38
▸ TP53 P04637 2/20 0.38
▸ HSD11B1 P28845 2/20 0.37
▸ PDE2A O00408 2/20 0.36
▸ PGR P06401 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128486 0.93 HSD11B1 (0.46) POLBMAPTRORARORCRORB
SCHEMBL10128481 0.91 POLB (0.44) POLBMAPTRORARORCRORB
SCHEMBL10128667 0.89 POLB (0.42) POLBMAPTRORARORCRORB
SCHEMBL10127801 0.86 POLB (0.45) POLBMAPTRORARORCRORB
SCHEMBL10127726 0.86 POLB (0.45) POLBMAPTRORARORCRORB
SCHEMBL10128497 0.85 POLB (0.42) POLBMAPTTP53PDE2AALDH1A1
SCHEMBL10128482 0.83 POLB (0.44) POLBMAPTRORARORCRORB
SCHEMBL10128672 0.82 HSD11B1 (0.46) POLBMAPTRORARORCRORB
SCHEMBL10128528 0.81 RXFP1 (0.44) POLBMAPTTP53ALDH1A1HPGD
SCHEMBL10128499 0.81 POLB (0.47) POLBMAPTPDE2AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 — — US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 — — US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 — — WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 — — US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 POLB 3317/4885MAPT 1271/4885RORA 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.